EP3823631
METHODS OF TREATING HFPEF EMPLOYING DAPAGLIFLOZIN AND COMPOSITIONS COMPRISING THE SAME
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
18.7.2019EP published:
20.5.2026EP application number:
19759294.2
EPO information:
European Patent Register
Max expiry date:
17.7.2039Expiry date:
19.9.2026
Title in English:
METHODS OF TREATING HFPEF EMPLOYING DAPAGLIFLOZIN AND COMPOSITIONS COMPRISING THE SAMELanguage of the patent:
English
Timeline
Today
18.7.2019EP application
20.5.2026EP Publication
19.9.2026Expires
Owner
Name:
Astrazeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
LANGKILDE, Anna, MariaAddress:
151 85 Södertälje, SE
Priority
Number:
201862700463 PDate:
19.7.2018Country:
US
Classification
Categories:
A61K 31/70, A61P 9/00, A61P 9/04